Skip to main content
. 2017 Jun 21;216(2):220–227. doi: 10.1093/infdis/jix294

Table 2.

Rotavirus Enzyme Immunoassay Result for Children 2–23 Months of Age Who Were Age Eligible and Age Ineligible to Receive at Least 1 Dose of Rotavirus Vaccine, for Africa Region Countries in Which Rotavirus Vaccine Was Introduced by 2014

Country No. Date of RV Introduction RV Type 2013/2014 Coverage Estimates, %a Age Eligible Age Ineligible
No. (%) Age (mo),
Mean ± SD
Rotavirus EIA Positive, No. % No. (%) Age (mo),
Mean ± SD
Rotavirus EIA Positive, No. (%)
Burkina Faso 694 November 2013 RotaTeq 9/91 155 (22.3) 6 ± 2.6 27 (17.4) 539 (77.7) 11.6 ± 4.3 292 (54.2)
Ghana 547 April 2012 Rotarix 87/98 468 (85.6) 10.4 ± 4.9 152 (32.5) 79 (14.4) 17.5 ± 3.6 28 (35.4)
The Gambia 186 August 2013 RotaTeq 90/92 40 (21.5) 7.5 ± 3.1 3 (7.5) 146 (78.5) 13.4 ± 5.3 41 (28.1)
Rwanda 1337 June 2012 RotaTeq >99/98 1098 (82.1) 11 ± 4.3 211 (19.2) 239 (17.9) 16.2 ± 3.9 77 (32.2)
South Africa 1086 August 2009 Rotarix 89/94 1086 (100) 9.6 ± 5.2 314 (28.9) 0 (0.0) NA NA
Senegal 157 November 2014 Rotarix NA/NA 0 (0.0) NA NA 157 (100.0) 9.7 ± 5.4 66 (42.0)
Sierra Leone 307 April 2014 Rotarix NA/70 1 (0.3) 3.0 ± 0.0 0 (0.0) 306 (99.7) 9.4 ± 4.4 142 (46.4)
Togo 342 July 2014 Rotarix NA/35 0 (0.0) NA NA 342 (100.0) 10.1 ± 4.6 203 (59.4)
Zambia 1816 December 2013 Rotarix NA/73 374 (20.6) 6.1 ± 2.4 115 (30.7) 1442 (79.4) 10.8 ± 5.1 565 (39.2)
Zimbabwe 1712 May 2014 Rotarix NA/82 80 (4.7) 5.2 ± 1.6 19 (23.8) 1632 (95.3) 11.1 ± 4.9 835 (51.2)
Overall 8184 3302 (40.3) 9.5 ± 4.8 841 (25.5) 4882 (59.7) 11.3 ± 5.1 2249 (46.1)

Abbreviations: EIA, enzyme immunoassay; NA, not applicable; RV, rotavirus vaccine; SD, standard deviation.

aVaccine coverage estimates for a complete course (from the World Health Organization vaccine-preventable disease monitoring system, 2016 global summary; available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragerotac.html).